Pharma Mar (OTCMKTS:PHMMF) Hits New 12-Month High at $54.00

Pharma Mar, S.A. (OTCMKTS:PHMMF)’s share price reached a new 52-week high during trading on Friday . The company traded as high as $54.00 and last traded at $54.00, with a volume of 243 shares. The stock had previously closed at $45.85.

Wall Street Analysts Forecast Growth

Separately, Chardan Capital upgraded Pharma Mar to a “strong-buy” rating in a research report on Thursday, August 1st.

Pharma Mar Trading Up 17.8 %

The firm’s fifty day moving average price is $39.33 and its 200 day moving average price is $33.76. The company has a quick ratio of 2.22, a current ratio of 2.63 and a debt-to-equity ratio of 0.14.

Pharma Mar Company Profile

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, France, rest of EU, the United States, and internationally. The company operates through Oncology and RNA interference segments.